[{"address1": "1540 Broadway", "address2": "24th Floor", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "212 295 5800", "website": "https://www.schrodinger.com", "industry": "Health Information Services", "sector": "Healthcare", "longBusinessSummary": "Schr\u00f6dinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schr\u00f6dinger, Inc. was incorporated in 1990 and is based in New York, New York.", "fullTimeEmployees": 867, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ramy  Farid Ph.D.", "age": 58, "title": "CEO, President & Director", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 1056378, "exercisedValue": 1144419, "unexercisedValue": 32715528}, {"maxAge": 1, "name": "Dr. Richard A. Friesner Ph.D.", "age": 70, "title": "Co-Founder, Scientific Advisory Chairman and Director", "yearBorn": 1953, "fiscalYear": 2023, "totalPay": 465000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Geoffrey Craig Porges MBBS", "title": "Executive VP & CFO", "fiscalYear": 2023, "totalPay": 888148, "exercisedValue": 0, "unexercisedValue": 435000}, {"maxAge": 1, "name": "Dr. Robert Lorne Abel Ph.D.", "age": 41, "title": "Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 569448, "exercisedValue": 0, "unexercisedValue": 2285285}, {"maxAge": 1, "name": "Dr. Karen  Akinsanya Ph.D.", "age": 55, "title": "President of Research & Development Therapeutics", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 797737, "exercisedValue": 0, "unexercisedValue": 5435442}, {"maxAge": 1, "name": "Dr. Margaret Han  Dugan M.D.", "age": 66, "title": "Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 707457, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. William  Goddard III", "title": "Co-Founder & Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kenneth Patrick Lorton", "age": 39, "title": "Executive VP, CTO & COO of Software", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 510091, "exercisedValue": 395900, "unexercisedValue": 718329}, {"maxAge": 1, "name": "Mr. Shane  Brauner", "age": 45, "title": "Executive VP & Chief Information Officer", "yearBorn": 1978, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yvonne  Tran Esq.", "age": 52, "title": "Corporate Secretary, Chief Legal & People Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 670101, "exercisedValue": 0, "unexercisedValue": 1018071}], "auditRisk": 2, "boardRisk": 7, "compensationRisk": 6, "shareHolderRightsRisk": 3, "overallRisk": 4, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 20.35, "open": 20.37, "dayLow": 20.03, "dayHigh": 20.68, "regularMarketPreviousClose": 20.35, "regularMarketOpen": 20.37, "regularMarketDayLow": 20.03, "regularMarketDayHigh": 20.68, "beta": 1.504, "forwardPE": -8.240964, "volume": 429866, "regularMarketVolume": 429866, "averageVolume": 691845, "averageVolume10days": 490680, "averageDailyVolume10Day": 490680, "bid": 20.47, "ask": 20.56, "bidSize": 200, "askSize": 400, "marketCap": 1493784192, "fiftyTwoWeekLow": 18.02, "fiftyTwoWeekHigh": 38.0, "priceToSalesTrailing12Months": 7.4455786, "fiftyDayAverage": 20.7015, "twoHundredDayAverage": 25.519375, "currency": "USD", "enterpriseValue": 1228049408, "profitMargins": -1.00418, "floatShares": 62100538, "sharesOutstanding": 63632300, "sharesShort": 8408962, "sharesShortPriorMonth": 8202524, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.1155, "heldPercentInsiders": 0.02394, "heldPercentInstitutions": 0.95647, "shortRatio": 10.84, "shortPercentOfFloat": 0.21209998, "bookValue": 6.512, "priceToBook": 3.1511056, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -201464992, "trailingEps": -2.79, "forwardEps": -2.49, "pegRatio": 2.01, "enterpriseToRevenue": 6.121, "enterpriseToEbitda": -6.125, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "SDGR", "underlyingSymbol": "SDGR", "shortName": "Schrodinger, Inc.", "longName": "Schr\u00f6dinger, Inc.", "firstTradeDateEpochUtc": 1580999400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "b77e6f29-1130-3c9c-84b4-f61a43ab5f20", "gmtOffSetMilliseconds": -14400000, "currentPrice": 20.52, "targetHighPrice": 50.0, "targetLowPrice": 25.0, "targetMeanPrice": 33.27, "targetMedianPrice": 30.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 11, "totalCash": 377288992, "totalCashPerShare": 5.183, "ebitda": -200512000, "totalDebt": 123929000, "quickRatio": 4.305, "currentRatio": 4.503, "totalRevenue": 200627008, "debtToEquity": 26.146, "revenuePerShare": 2.777, "returnOnAssets": -0.16829, "returnOnEquity": -0.37129003, "freeCashflow": -124073000, "operatingCashflow": -180195008, "revenueGrowth": 0.345, "grossMargins": 0.65502, "ebitdaMargins": -0.99943, "operatingMargins": -1.11398, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]